Alexium to Supply AlexiflamTM and AlexicoolTM to Two U.S. Mattress Ticking Producers in US$3 Million Per Year Agreements
Alexium’s First Multifunction, Single-Formulation Chemistries Agreements Are For 3-Year Period
Perth, Australia and Greer, South Carolina – 19 October 2016 -- Alexium International Group Limited (“Alexium,” “the Company”) (ASX:AJX, OTC QX:AXXIY) has signed its first multifunction, single-chemical formulation sales agreements to supply its flame retardant (FR) (AlexiflamTM), phase change cooling technology (AlexicoolTM) and an odor preventer for mattress ticking. These agreements are between Alexium and two separate U.S.-based major producers and finishers of mattress fabrics for joint supply to one of the largest mattress brands in the world.
Sales are expected to commence immediately with monthly revenue to continue over an initial three-year production period, representing sales revenues in excess of US$3 million per year. Under these agreements, Alexium will supply its chemistry to three locations worldwide, with the end bedding products being sold primarily in stores in the United States.
Following Alexium’s success with its AlexiflamTM and AlexicoolTM products in the bedding market, the company sought to provide a single chemical package comprising a number of products and functions to help its customers reduce production time and complexity. These sales agreements are Alexium’s first successful implementation of that approach. This new approach to the bedding market allows Alexium to capitalize on its expert knowledge of proprietary chemistry formulations to provide customized solutions to its customers and maintain strong margins, while its customers are responsible for the production process.
“When we first entered the bedding sector with our initial FR product, AlexiflamTM, we quickly established ourselves as not only a provider of high-quality FR products but also as a highly capable partner for providing complex chemical solutions reliably,” stated Dirk Van Hyning, President of Alexium. “These multifunction, single-formulation agreements are a major step forward for Alexium as we expand our capabilities in the marketplace.”
Mr. Van Hyning added, “We have been in discussions with other bedding fabric producers and finishers and anticipate further interest in our multifunction, single-formulation chemistries. We also expect this broader approach to the chemical marketplace will be very successful in other industries such as apparel, footwear and beyond.”
Highlights
Alexium to produce AlexicoolTM for two leading global mattress makers for three years
- Alexium’s chemistry chosen for superior performance
- Purchase and Production has already commenced
- Forums
- ASX - By Stock
- AJX
- Ann: US$3m First Multifunction, Single-Formulation Agreements-AJX.AX
Ann: US$3m First Multifunction, Single-Formulation Agreements-AJX.AX, page-2
-
-
- There are more pages in this discussion • 115 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AJX (ASX) to my watchlist
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $12.49M |
Open | High | Low | Value | Volume |
0.8¢ | 0.8¢ | 0.8¢ | $1.864K | 233.0K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 1258409 | 0.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.9¢ | 57000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 1258409 | 0.008 |
6 | 3850194 | 0.007 |
4 | 581167 | 0.006 |
1 | 300000 | 0.005 |
1 | 500000 | 0.004 |
Price($) | Vol. | No. |
---|---|---|
0.009 | 57000 | 1 |
0.010 | 150000 | 2 |
0.011 | 1000000 | 2 |
0.013 | 669958 | 2 |
0.014 | 134311 | 1 |
Last trade - 14.36pm 30/08/2024 (20 minute delay) ? |
Featured News
AJX (ASX) Chart |
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online